Market Cap (In CNY)
22.95 Billion
Revenue (In CNY)
10.31 Billion
Net Income (In CNY)
1.35 Billion
Avg. Volume
15.97 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 14.37-24.47
- PE
- -32.71
- EPS
- -0.42
- Beta Value
- 0.221
- ISIN
- CNE1000015S0
- CUSIP
- -
- CIK
- -
- Shares
- 1670710000.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Xiang Jun Wu
- Employee Count
- -
- Website
- https://www.yiling.cn
- Ipo Date
- 2011-07-28
- Details
- Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of medicine primarily in China. The company operates through Chemical and Biological Medicine, and Health Industry segments. It offers drugs for cardiac and premature ventricular beats, sinus bradycardia, chronic heart failure, integrated rhythm regulation, cold and respiratory, cardiovascular and cerebrovascular diseases, diabetes field, tumor medication, and others. The company sells its products through physical display and online. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is based in Shijiazhuang, China.
More Stocks
-
300417Nanhua Instruments Co., Ltd.
300417
-
RIVN
-
DELTA
-
BANBBachem Holding AG
BANB
-
KRITINUTKriti Nutrients Limited
KRITINUT
-
ORIENTALTLOriental Trimex Limited
ORIENTALTL
-
HPOL-BHEXPOL AB (publ)
HPOL-B
-
LAMM-B